Acute Respiratory Tract Infections and Severe Disease Among Hospitalized Children

Haifa Mtaweh1,2,3,4, Caitlyn L Kaziev2, Carlee A Feinstein2

  • 1Department of Critical Care Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.

JAMA Network Open
|June 9, 2026
PubMed

Insights

Hospitalized children with viral respiratory tract infections (RTIs) often have chronic conditions. Comorbidities and transfers increase the risk of severe outcomes in pediatric patients with acute RTIs.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Critical Care Medicine

Background:

  • Viral respiratory tract infections (RTIs) epidemiology in children is dynamic, influenced by transmission, seasonality, immunity, and major events like pandemics.
  • Understanding these changes is crucial for managing pediatric respiratory illnesses.

Purpose of the Study:

  • To describe clinical characteristics and outcomes of children hospitalized with acute RTIs.
  • To identify factors associated with an increased risk of severe disease in this pediatric population.

Main Methods:

  • A retrospective cohort study involving 2585 children (0-18 years) hospitalized with acute RTIs across two Canadian children's hospitals.
  • Data collected included demographics, clinical factors, viral testing results, management, and outcomes, with severe disease defined by critical interventions or death.
  • Multivariable robust Poisson regression analyzed risk factors for severe outcomes.

Main Results:

  • Respiratory syncytial virus and enterovirus-rhinovirus were the most common viral pathogens identified.
  • Over 21% of hospitalized children developed severe disease, with higher risks observed in those with multiple comorbidities or transfer from referring institutions.
  • Children with 2+ comorbidities had an adjusted risk ratio (aRR) of 1.62 for severe disease, while transferred patients had an aRR of 4.73.

Conclusions:

  • Hospitalized children with acute RTIs frequently present with underlying chronic conditions and necessitate intensive care.
  • Factors such as multiple comorbidities and inter-facility transfer significantly elevate the risk of severe disease.
  • Insights into the epidemiologic profile and risk factors can guide resource allocation to improve outcomes for pediatric patients with RTIs.
Abstract

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: